Hydrochloric Acid → HCID 11167116, compound
Reaction equation
[NH:1]1[CH2:6][CH2:5][CH:4]([CH2:7][NH:8][C:9]2[S:10][C:11]([C:14]([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=3[CH3:22])=[O:15])=[CH:12][N:13]=2)[CH2:3][CH2:2]1.Cl.[S:24]1[CH:28]=[CH:27][CH:26]=[C:25]1[S:29](Cl)(=[O:31])=[O:30].CCN(CC)CC>C(Cl)Cl.CO>[S:24]1[CH:28]=[CH:27][CH:26]=[C:25]1[S:29]([N:1]1[CH2:6][CH2:5][CH:4]([CH2:7][NH:8][C:9]2[S:10][C:11]([C:14]([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=3[CH3:22])=[O:15])=[CH:12][N:13]=2)[CH2:3][CH2:2]1)(=[O:31])=[O:30]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 60 °C
Procedure
A mixture of 35.2 mg (0.1 mmol) {2-[(piperidin-4-ylmethyl)-amino]-thiazol-5-yl}-o-tolyl-methanone; hydrochloride, 21.9 mg (0.12 mmol) thiophene-2-sulfonyl chloride (commercially available) and 44.6 ul (0.32 mmol) NEt3 in a mixture of DCM/MeOH 3/1 was stirred at 60° C. for 16 h. After cooling to room temperature the mixture was concentrated and MeOH (1 ml) and formic acid (0.5 ml) was added and the mixture was subjected to reversed phase HPLC purification eluting with a gradient of acetonitrile/water. After evaporation of the product fractions 22 mg (48%) of the title compound was obtained.
Workup
- temperatureAfter cooling to room temperature the mixture
- concentrationwas concentrated
- additionMeOH (1 ml) and formic acid (0.5 ml) was added
- customthe mixture was subjected to reversed phase HPLC purification
- washeluting with a gradient of acetonitrile/water
- customAfter evaporation of the product fractions 22 mg (48%) of the title compound
- customwas obtained
Sources & evidence
- ORD record
- ord-46d74d72fc4f40e2b41a4b9911da9c10
- Source dataset
- uspto-grants-2007_09
- Patent number
- US07265109B2
Reaction notes
Loading…